1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow AVE9633: new trials by email Literature Review of AVE9633 trials Research Report on AVE9633
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia AVE9633 - Myeloid Leukemia | Phase 1 | Terminated | Sanofi | 12 | 2007-09-01 | 2009-05-14 |
Sanofi (1)
France (1) · Spain (1) · United States (1)